Literature DB >> 3521832

Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II.

G A Higgins, E W Humphrey, R W Dwight, B Roswit, L E Lee, R J Keehn.   

Abstract

In a prospective randomized trial, 361 male patients with histologically proven adenocarcinoma of the rectum, judged preoperatively to require abdominoperineal resection (APR), were treated by surgery alone or were given 3,150 rads of preoperative radiotherapy. Surgical resection was done on 320 patients, 262 having "curative" APR. Only moderate symptoms from radiotherapy were noted and postoperative complications and 30-day mortality were similar in both groups. Five-year survival for curative APR was the same in both groups (50% for both treated and control patients). The incidence of positive lymph nodes in the resected specimens was 35% in treated and 41% in controls. In the first preoperative radiotherapy trial conducted by the group, 5-year survival in patients undergoing "curative" APR was 47% in treated versus 34% in control groups. Additionally, the difference in positive lymph nodes in the resected specimens was substantially greater in the first trial (26% in treated versus 44% in controls).

Entities:  

Mesh:

Year:  1986        PMID: 3521832     DOI: 10.1002/1097-0142(19860715)58:2<352::aid-cncr2820580226>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

Review 1.  Optimising treatment for resectable rectal cancer: is preoperative therapy beneficial?

Authors:  S Y Ngan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Surgical excision alone is adequate treatment for primary colorectal cancer.

Authors:  R Hind; D R Rew; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

3.  Pre-operative radiotherapy as adjuvant treatment in rectal cancer.

Authors:  F Izar; G Fourtanier; B Pradere; P Chiotasso; E Bloom; I Fontes-Dislaire; R Bugat; N Daly
Journal:  World J Surg       Date:  1992 Jan-Feb       Impact factor: 3.352

Review 4.  Interval to surgery after neoadjuvant treatment for colorectal cancer.

Authors:  Nir Wasserberg
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).

Authors:  A Gérard; M Buyse; B Nordlinger; J Loygue; F Pène; P Kempf; J F Bosset; M Gignoux; J P Arnaud; C Desaive
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

6.  [Value of radiotherapy in the treatment of rectal cancer].

Authors:  M Wannenmacher
Journal:  Langenbecks Arch Chir       Date:  1987

Review 7.  Electrocoagulation for adenocarcinoma of the low rectum.

Authors:  T E Eisenstat; G C Oliver
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

8.  Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group.

Authors: 
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

9.  Adjuvant treatment in colorectal cancer: an update.

Authors:  H O Douglass
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

10.  Surgical strategies in locoregional recurrences of gastrointestinal carcinoma.

Authors:  C Herfarth; P Schlag; P Hohenberger
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.